Free Trial
NASDAQ:ATNF

180 Life Sciences (ATNF) Stock Price, News & Analysis

180 Life Sciences logo
$3.42
-0.32 (-8.56%)
(As of 12:35 PM ET)

About 180 Life Sciences Stock (NASDAQ:ATNF)

Key Stats

Today's Range
$3.38
$3.71
50-Day Range
$1.18
$6.47
52-Week Range
$1.16
$17.75
Volume
207,491 shs
Average Volume
825,445 shs
Market Capitalization
$3.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Receive ATNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

ATNF Stock News Headlines

This company will win the AI race
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
Elray Resources Announces Strategic Sale of Crypto iGaming Technology
180 Life Sciences Corp Ordinary Shares
See More Headlines

ATNF Stock Analysis - Frequently Asked Questions

180 Life Sciences' stock was trading at $4.0565 on January 1st, 2024. Since then, ATNF stock has decreased by 12.2% and is now trading at $3.56.
View the best growth stocks for 2024 here
.

180 Life Sciences Corp. (NASDAQ:ATNF) announced its quarterly earnings results on Monday, August, 12th. The company reported $0.01 earnings per share for the quarter.

180 Life Sciences shares reverse split before market open on Wednesday, February 28th 2024. The 1-19 reverse split was announced on Wednesday, February 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that 180 Life Sciences investors own include Meta Platforms (META), NIO (NIO), Enterprise Products Partners (EPD), HubSpot (HUBS), Netflix (NFLX), Palantir Technologies (PLTR) and Plug Power (PLUG).

Company Calendar

Last Earnings
8/12/2024
Today
11/04/2024
Next Earnings (Estimated)
11/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATNF
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-19,930,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.24) per share

Miscellaneous

Free Float
985,000
Market Cap
$3.67 million
Optionable
No Data
Beta
0.22
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:ATNF) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners